![](/img/cover-not-exists.png)
195 RESULTS OF A MULTI-CENTER, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF CP-0127, A NOVEL BRADYKININ ANTAGONIST. IN PATIENTS WITH SIRS AND SEPSIS
Rodell, T. C., Scharschmidt, L. A., Knaus, W. A.Volume:
3
Journal:
Shock
DOI:
10.1097/00024382-199505000-00195
Date:
May, 1995
File:
PDF, 97 KB
1995